The story of Viagra offers a intricate case study for stakeholders eyeing the pharmaceutical sector. While initial sales were remarkable, current patent expiration and the rise of alternative versions have considerably https://philipxhtk693774.bloguetechno.com/the-blue-pill-and-big-pharma-a-risky-bet-77639672